Judge Approves $25M Remicade Antitrust Settlement
PHILADELPHIA — A Pennsylvania federal judge on Aug. 2 granted preliminary approval of a $25 million class action antitrust settlement for indirect purchasers of the immunosuppressant drug Remicade....To view the full article, register now.
Already a subscriber? Click here to view full article